Cannabidiol and Heart Failure

Cannabidiol Limits T Cell–Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation

08/01/2016 by Molecular Medicine

Is the Cardiovascular system a Therapeutic target for Cannabidiol

02/02/2013 by British Journal of Clinical Pharmacology

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

14/12/2010 by Journal of the American College of Cardiology

Inflammation and Heart Failure

Innate immunity and the failing heart: the cytokine hypothesis revisited

27/03/2015 by Circulation Research

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

21/10/2014 by European Society of Cardiology

Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target

19/09/2014 by Heart Failure Reviews

The Global Health and Economic Burden of Hospitalizations for Heart Failure

01/04/2014 by Journal of the American College of Cardiology

Inflammation in Heart Failure with Preserved Ejection Fraction

01/04/2016 by Gomberg-Maitland et al., JACC: Heart Failure

Cannabidiol and Inflammation

Cannabidiol Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma

15/01/2019 by Vuolo et al., European Journal of Pharmacology

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis

01/06/2018 by Petrosino et al., Journal of Pharmacology and Experimental Therapeutics

Cannabidiol (CBD) and its Analogs: A Review of Their Effects on Inflammation

04/01/2015 by Burstein Bioorganic & Medicinal Chemistry